AccessHope (@myaccesshope) 's Twitter Profile
AccessHope

@myaccesshope

Changing the way leading-edge cancer expertise is delivered. Helping progressive employers unlock access to sub-specialist knowledge and insights.

ID: 1148651532516122624

linkhttps://hubs.la/H0TZ3Sp0 calendar_today09-07-2019 17:54:01

383 Tweet

243 Followers

291 Following

AccessHope (@myaccesshope) 's Twitter Profile Photo

We celebrate the strength and resilience of cancer survivors everywhere. Survivorship isn’t just about beating cancer—it’s about navigating the challenges that come after. Employers can make a difference by fostering a workplace that’s empathetic, flexible, and supportive.

We celebrate the strength and resilience of cancer survivors everywhere. Survivorship isn’t just about beating cancer—it’s about navigating the challenges that come after. Employers can make a difference by fostering a workplace that’s empathetic, flexible, and supportive.
AccessHope (@myaccesshope) 's Twitter Profile Photo

We’re gearing up for #QuantumHealthConnect tomorrow! Excited to connect with HR leaders and benefits pros focused on advancing care and outcomes. Let’s talk smarter cancer support and better benefit strategies. quantum-health.com/quantum-health… Quantum Health #CancerCare

We’re gearing up for #QuantumHealthConnect tomorrow! Excited to connect with HR leaders and benefits pros focused on advancing care and outcomes.

Let’s talk smarter cancer support and better benefit strategies.

quantum-health.com/quantum-health…

<a href="/QuantumHealth1/">Quantum Health</a> #CancerCare
AccessHope (@myaccesshope) 's Twitter Profile Photo

Cancer myths can delay diagnosis and derail treatment. In @KevinMD, our Chief Clinical Advisor, Joseph Alvarnas, debunks common misconceptions—from heredity to alternative cures—and shares why facts matter. Knowledge saves lives. #CancerCare kevinmd.com/2025/06/5-canc…

Cancer myths can delay diagnosis and derail treatment. In @KevinMD, our Chief Clinical Advisor, Joseph Alvarnas, debunks common misconceptions—from heredity to alternative cures—and shares why facts matter. Knowledge saves lives. #CancerCare

kevinmd.com/2025/06/5-canc…
AccessHope (@myaccesshope) 's Twitter Profile Photo

We’ve strengthened our leadership team with four new executives who bring deep expertise in healthcare, innovation, and business development. With these additions, we’re even better positioned to scale expert #cancersupport through strategic partnerships with employers, health

We’ve strengthened our leadership team with four new executives who bring deep expertise in healthcare, innovation, and business development. With these additions, we’re even better positioned to scale expert #cancersupport through strategic partnerships with employers, health
AccessHope (@myaccesshope) 's Twitter Profile Photo

“What’s a cancer #clinicaltrial—and is it right for me?” Our blog breaks it down in simple terms: what trials are, who can join, why they matter, and how to find one. A must-read for patients, caregivers & advocates. #CancerCare Read more: myaccesshope.org/blog/everythin…

“What’s a cancer #clinicaltrial—and is it right for me?” Our blog breaks it down in simple terms: what trials are, who can join, why they matter, and how to find one. A must-read for patients, caregivers &amp; advocates. #CancerCare

Read more: myaccesshope.org/blog/everythin…
AccessHope (@myaccesshope) 's Twitter Profile Photo

Our Chief Clinical Advisor, Dr. Joseph Alvarnas, sat down with @AuthorityMagzine to discuss the “5 Things Everyone Needs to Know About Cancer.” He shares the latest cutting-edge treatment options and dispels the biggest myths about #cancer. medium.com/authority-maga…

Our Chief Clinical Advisor, Dr. Joseph Alvarnas, sat down with @AuthorityMagzine to discuss the “5 Things Everyone Needs to Know About Cancer.” He shares the latest cutting-edge treatment options and dispels the biggest myths about #cancer.  medium.com/authority-maga…
AccessHope (@myaccesshope) 's Twitter Profile Photo

A second opinion changes the diagnosis or treatment plan in up to 43% of breast cancer cases—yet most women never get one. Employers can help close this gap by making expert opinions easier to access. Learn more in our latest blog. myaccesshope.org/blog/why-secon… #BreastCancer

A second opinion changes the diagnosis or treatment plan in up to 43% of breast cancer cases—yet most women never get one. Employers can help close this gap by making expert opinions easier to access. Learn more in our latest blog.

myaccesshope.org/blog/why-secon…

#BreastCancer
AccessHope (@myaccesshope) 's Twitter Profile Photo

June is Men’s Health Month, highlighting the important but often overlooked issues men face. 1 in 3 men will be diagnosed with cancer, yet many delay screenings for prostate and colorectal cancers, which can develop without early symptoms. If you’re 45+ or have a family history,

June is Men’s Health Month, highlighting the important but often overlooked issues men face. 1 in 3 men will be diagnosed with cancer, yet many delay screenings for prostate and colorectal cancers, which can develop without early symptoms. If you’re 45+ or have a family history,
AccessHope (@myaccesshope) 's Twitter Profile Photo

Driven by a belief that everyone deserves expert cancer care, Dr. Yousuf Zafar, MD, MHS, works to close gaps in cancer treatment. At AccessHope, he combines clinical expertise with a passion for transforming cancer care—no matter where you live. In this Q&A, he shares what led

Driven by a belief that everyone deserves expert cancer care, Dr. Yousuf Zafar, MD, MHS, works to close gaps in cancer treatment. At AccessHope, he combines clinical expertise with a passion for transforming cancer care—no matter where you live.

In this Q&amp;A, he shares what led
AccessHope (@myaccesshope) 's Twitter Profile Photo

The cost of cancer care is more than a number—it can shape outcomes. Financial toxicity affects whether people with cancer stick with treatment, fill prescriptions, or follow up with providers. Dr. Yousuf Zafar, MD, MHS, breaks it down and shares how to get help. #CancerCare

The cost of cancer care is more than a number—it can shape outcomes. Financial toxicity affects whether people with cancer stick with treatment, fill prescriptions, or follow up with providers. Dr. Yousuf Zafar, MD, MHS, breaks it down and shares how to get help. #CancerCare
AccessHope (@myaccesshope) 's Twitter Profile Photo

Cancer care is advancing at a rapid pace—and the gap between innovation and access is growing. On the HealthTech Remedy podcast, our chief medical officer, Yousuf Zafar, MD MHS, shares how expert second opinions, clinical trials, and health tech can change outcomes. Listen:

Cancer care is advancing at a rapid pace—and the gap between innovation and access is growing. On the HealthTech Remedy podcast, our chief medical officer, <a href="/yzafar/">Yousuf Zafar, MD MHS</a>, shares how expert second opinions, clinical trials, and health tech can change outcomes. Listen:
AccessHope (@myaccesshope) 's Twitter Profile Photo

What’s the difference between a second opinion and an expert cancer review? @AccessHope’s CMO, Dr. Yousuf Zafar explains—recent data showing 75% of our expert recommendations are implemented in care. #CancerCare #SecondOpinions #EmployeeBenefits #ExpertCancerCare

What’s the difference between a second opinion and an expert cancer review?  @AccessHope’s CMO, Dr. Yousuf Zafar explains—recent data showing 75% of our expert recommendations are implemented in care.

#CancerCare #SecondOpinions #EmployeeBenefits #ExpertCancerCare
AccessHope (@myaccesshope) 's Twitter Profile Photo

What drives better cancer care? It starts with understanding the whole patient. Yousuf Zafar, MD MHS joins Dr. Eric Fethke on The Pursuit of Health to discuss precision care, financial toxicity, second opinions & improving access nationwide. Listen: buzzsprout.com/1528001/episod… #CancerCare

What drives better cancer care? It starts with understanding the whole patient. <a href="/Yzafar/">Yousuf Zafar, MD MHS</a> joins <a href="/EricFethkeMD/">Dr. Eric Fethke</a> on The Pursuit of Health to discuss precision care, financial toxicity, second opinions &amp; improving access nationwide.
Listen: buzzsprout.com/1528001/episod…
 #CancerCare
AccessHope (@myaccesshope) 's Twitter Profile Photo

We’re proud to partner with National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers that continue to lead with innovation and compassion in the fight against cancer. Congratulations to @CityofHope , Dana-Farber, @FredHutch, @HopkinsKimmel Northwestern Medicine,

We’re proud to partner with National Cancer Institute (NCI)-Designated Comprehensive Cancer Centers that continue to lead with innovation and compassion in the fight against cancer. Congratulations to @CityofHope , <a href="/DanaFarber/">Dana-Farber</a>, @FredHutch, @HopkinsKimmel <a href="/NorthwesternMed/">Northwestern Medicine</a>,
AccessHope (@myaccesshope) 's Twitter Profile Photo

August is National Wellness Month, a timely reminder to prioritize self-care and cultivate healthy habits every day, even during a cancer journey. Cancer can disrupt routines and make balance feel out of reach. But with the right support, individuals can focus on what they can

August is National Wellness Month, a timely reminder to prioritize self-care and cultivate healthy habits every day, even during a cancer journey.

Cancer can disrupt routines and make balance feel out of reach. But with the right support, individuals can focus on what they can
AccessHope (@myaccesshope) 's Twitter Profile Photo

Cancer treatment is complex and rapidly evolving, making access to subspecialists essential. Yet, according to a study published in BMC Palliative Care, 84% of patients do not seek a second opinion, even though differing expert opinions can significantly impact outcomes. From

Cancer treatment is complex and rapidly evolving, making access to subspecialists essential. Yet, according to a study published in BMC Palliative Care, 84% of patients do not seek a second opinion, even though differing expert opinions can significantly impact outcomes. From
AccessHope (@myaccesshope) 's Twitter Profile Photo

The Business Group on Health 2026 survey shows employers are under more pressure than ever to improve health care and manage rising costs. Cancer is the #1 driver of health care spending for the fourth year in a row. At AccessHope, we connect employees and their treating oncologists with top

The <a href="/BizGrpHlth/">Business Group on Health</a> 2026 survey shows employers are under more pressure than ever to improve health care and manage rising costs. Cancer is the #1 driver of health care spending for the fourth year in a row.

At AccessHope, we connect employees and their treating oncologists with top
AccessHope (@myaccesshope) 's Twitter Profile Photo

HR & benefits leaders: Think you know #cancercare? Think again. Join AccessHope’s chief medical officer and oncologist Yousuf Zafar, MD MHS + Employee Benefit News for a myth-busting webinar on cancer care, cost & access. September 16, at 2 PM ET | 11 AM PT Register now: linkprotect.cudasvc.com/url?a=https%3a…

HR &amp; benefits leaders: Think you know #cancercare? Think again. Join AccessHope’s chief medical officer and oncologist <a href="/yzafar/">Yousuf Zafar, MD MHS</a> + <a href="/EBNbenefitnews/">Employee Benefit News</a> for a myth-busting webinar on cancer care, cost &amp; access.

September 16, at 2 PM ET | 11 AM PT
Register now: linkprotect.cudasvc.com/url?a=https%3a…
AccessHope (@myaccesshope) 's Twitter Profile Photo

September is Prostate Cancer Awareness Month. Prostate cancer is one of the most common cancers among men, yet awareness about risks, early signs, and screening options remains low. Age, family history, and lifestyle all play a role, but early detection and knowing your options

September is Prostate Cancer Awareness Month.

Prostate cancer is one of the most common cancers among men, yet awareness about risks, early signs, and screening options remains low. Age, family history, and lifestyle all play a role, but early detection and knowing your options
AccessHope (@myaccesshope) 's Twitter Profile Photo

Colorectal cancer rates are rising in younger adults, but screening is starting to make a difference. According to a recent JAMA study, screening among adults ages 45–49 increased from 21% in 2019 to 34% in 2023 after guidelines lowered the age to 45. As a result,

Colorectal cancer rates are rising in younger adults, but screening is starting to make a difference.

According to a recent <a href="/JAMA_current/">JAMA</a> study, screening among adults ages 45–49 increased from 21% in 2019 to 34% in 2023 after guidelines lowered the age to 45. As a result,